Delivery Order SPE2DE24D0021-SPE2D625F3UQB
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,394.40 by the Department of Defense's Medical Supply Chain for the provision of vaginal positive control solutions (6 x 0.9 mL per unit). The contract, awarded on September 11, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by September 18, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order on September 9, 2025, valued at $2,772.01 for the procurement of vaginal positive control solutions (6x0.9ml per unit) from the Defense Medical Supply Chain. This is a fixed price contract with economic price adjustment provisions, with a completion date of September 16, 2025. The contract was awarded without a set-aside designation through open competition, and will be fulfilled at Fisher Scientific's Pittsburgh, Pennsylvania...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,540.15 for vaginal positive control material (6 units of 0.9 milliliters each) by the Medical Supply Chain, a defense-focused federal agency. The contract, awarded on September 15, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for ultimate completion by September 22, 2025. The award represents an open competition procurement with no set-aside...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,883.44 for vaginal positive control specimens (6 units × 0.9 milliliters each) by the Department of Defense's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is set for completion by September 17, 2025, and will be performed in Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order represents a routine procurement of specialized...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,154.16 by the Department of Defense's Medical Supply Chain on August 6, 2025, for the procurement of vaginal positive control material (6 units at 0.9 milliliters each). This fixed-price delivery order with economic price adjustment authority is scheduled for ultimate completion by August 13, 2025, with performance to be fulfilled in Pittsburgh, Pennsylvania. The contract was awarded through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,953.78 by the Defense Medical Supply Chain on August 14, 2025, for the supply of vaginal positive control material in 6x0.9ml units. The contract, which employs fixed-price pricing with economic price adjustment terms, carries a completion date of August 21, 2025, and will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,012.58 by the Department of Defense's Medical Supply Chain on August 12, 2025, for the provision of vaginal positive control reagent (6 units at 0.9 milliliters each). This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 19, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award utilized open competition without set-aside designations, reflecting...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,605.04 on August 7, 2025, for the procurement of vaginal positive control reagents (6 units of 0.9 milliliters each) to support medical supply chain operations for the Department of Defense. The contract is fixed price with economic price adjustment provisions and carries an ultimate completion date of August 14, 2025. Performance will be executed in Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,491.98 on August 6, 2025, for the supply of vaginal positive control material (6 units at 0.9 milliliters each). This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 13, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Defense Medical Supply Chain, a defense-focused federal agency supporting military and related healthcare...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,425.78 on August 13, 2025, for the procurement of vaginal negative control specimens (6 x 0.9 milliliter each). This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The funding agency is...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3UQBDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,697.20 on September 18, 2025, for the procurement of vaginal positive control solution (6 × 0.9 milliliter units) to support the Department of Defense Medical Supply Chain. The contract is fixed-price with economic price adjustment provisions and carries an ultimate completion date of September 25, 2025. This delivery order represents a child contract under a larger vehicle and was awarded through open competition with no set-aside designation, reflecting Fisher Scientific's established capability to compete effectively in federal procurement. The place of performance is identified as Pittsburgh, Pennsylvania. Fisher Scientific, a major for-profit supplier of scientific products and medical equipment registered in the System for Award Management since July 2001, continues its extensive relationship with federal agencies including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense. The company maintains significant blanket purchase agreements and multiple award schedule contracts across the federal government, specializing in laboratory supplies, medical equipment, and specialized testing solutions. This particular delivery order aligns with Fisher Scientific's broader portfolio of providing essential medical and laboratory supplies to support government healthcare and defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/18/25 |